RAUMEDIC
RAUMEDIC AG, headquartered in Germany, is a leading player in the medical technology industry, specialising in the development and production of high-quality polymer solutions for medical applications. Founded in 1949, the company has established a strong presence in Europe and North America, focusing on critical areas such as catheter systems, tubing, and custom medical devices. With a commitment to innovation, RAUMEDIC stands out for its advanced manufacturing processes and expertise in biocompatible materials. The company’s core products are designed to meet stringent regulatory standards, ensuring safety and reliability in healthcare settings. RAUMEDIC has achieved notable milestones, including certifications that underscore its dedication to quality and excellence in the medical field. As a trusted partner for healthcare providers, RAUMEDIC continues to enhance patient care through its cutting-edge solutions.
DitchCarbon Score
How does RAUMEDIC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RAUMEDIC's score of 6 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
RAUMEDIC's reported carbon emissions
In 2022, RAUMEDIC reported total carbon emissions of approximately 84,921,000 kg CO2e. This figure includes 2,329,000 kg CO2e from Scope 1 emissions, 7,148,000 kg CO2e from Scope 2 emissions, and a significant 75,444,000 kg CO2e from Scope 3 emissions. The emissions data for 2021 was identical, indicating a stable emissions profile over the two years. RAUMEDIC has not disclosed any specific reduction targets or initiatives as part of their climate commitments. However, the company is actively monitoring its greenhouse gas emissions, with a reported GHG emissions intensity of 1,480 kg CO2e per tonne of product sold in 2022, down from 2,860 kg CO2e per tonne in 2021 for Scope 1 and 2 emissions combined. This suggests a focus on improving efficiency and reducing emissions intensity in their operations. Overall, while RAUMEDIC has not set formal reduction targets, their consistent emissions data and decreasing emissions intensity indicate a commitment to sustainability and climate responsibility within the medical technology industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 2,329,000 | 0,000,000 |
| Scope 2 | 7,148,000 | 0,000,000 |
| Scope 3 | 75,444,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RAUMEDIC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
